Patentability Of Frontline Plus Formulation Claims Confirmed



Published:

Merial announced today the United States Patent and Trademark Office reconfirmed the patentability of formulation claims covering Merial’s Frontline Plus, a flea and tick control product.

“The ultimate result is that we expect some of the products infringing the formulation claims to be removed from the market.” says Judy Jarecki-Black, PhD, Esq., head of intellectual property with Merial, an animal health pharmaceutical company.

Additional information regarding companies involved with potential formulation infringement and actionable steps was expected to be released later this week, according to earlier information from a public relations representative. The release of the additional information is now expeted in coming weeks, according to Merial.

“We are pleased that the patent office confirmed the patentability of Merial’s inventions directed at fipronil and (S)-methoprene containing spot-on compositions,” Dr. Jarecki-Black says. “Merial is also pursuing litigation against other manufacturers in cases where it believes its patents have been violated. We plan to continue to vigorously defend our patent rights and continue our strong support of the veterinary profession.”

<Home>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Wisconsin Vet School to Launch Osteosarcoma Study

The University of Wisconsin School of Veterinary Medicine study is being funded by a grant from the Puppy Up Foundation.

New Animal Planet Series Stars Dr. Jeff Young of Planned Pethood Plus

The news series, "Dr Jeff: Rocky Mountain Vet" premieres July 11.

New Fast-Acting Gel Designed to Stop Blood Loss

Plant-based Vetigel may be used in biopsies, emergency care and other situations.

Add your comment:
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module